2026 NPPES data Optometrist NPI 1295367399
Verify on CMS →

NAYIRI ABNOUS

Optometrist in PASADENA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
785
Medicare Part D claims · 313 beneficiaries · Optometrist avg: 257
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.7K
75 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: NAYIRI ABNOUS is a Optometrist ([object Object]) practicing in PASADENA, California with a Medicare Part D prescribing footprint of 785 claims across 313 beneficiaries — 45% brand-name prescribing . Industry payments of $1.7K across 75 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: NAYIRI ABNOUS filed 785 Medicare Part D claims in 2023 across PASADENA, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

NAYIRI ABNOUS at a glance

Quality data not reported

NPI registry status

Active

Issued 02/06/2020

NPI 1295367399

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

785 205% vs specialty avg

2023 prescription claims

Specialty avg: 257

Specialty distribution in California

How Optometrist compares to other specialties among California providers

California providers

Optometrist share within California

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Optometrist ABMS/AOA estimate

Est. board-certified rate (Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAYIRI ABNOUS is a Optometrist provider practicing in PASADENA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1295367399. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NAYIRI ABNOUS appears in the CMS NPPES registry as a Optometrist provider at 2619 E COLORADO BLVD STE 150, PASADENA, CA, 91107, with a listed phone of (626) 793-4168. NPI 1295367399 was issued on 02/06/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABNOUS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 785 prescription claims written by this provider, covering 313 Medicare beneficiaries and totaling roughly $113K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2619 E COLORADO BLVD STE 150
PASADENA, CA 91107

Provider Details

NPI 1295367399
Specialty Optometrist
Gender Female
NPI Issued 02/06/2020

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAYIRI ABNOUS. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Oyster Point Pharma, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to NAYIRI ABNOUS. To verify NAYIRI ABNOUS's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NAYIRI ABNOUS — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 785 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

785
Total Claims
$113K
Total Drug Cost
313
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,038
Total Day Supply
27,861
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$104K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.99
Gender Split
62% female / 38% male
Age Distribution
<65: 12, 65-74: 123, 75-84: 134, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
275
Timolol Maleate
66
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
54
Restasis
Cyclosporine
45
Erythromycin
Erythromycin Base
43
Prednisolone Acetate
37
Brimonidine Tartrate
31
Azelastine Hcl
29
Ketorolac Tromethamine
28
Xiidra
Lifitegrast
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How NAYIRI ABNOUS fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

NAYIRI ABNOUS's 785 claims are above the specialty average of 257.

Nearby Optometrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ABNOUS.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAYIRI ABNOUS's specialty?
NAYIRI ABNOUS specializes in Optometrist and practices in PASADENA, California.
How much does NAYIRI ABNOUS prescribe under Medicare Part D?
In 2023, NAYIRI ABNOUS wrote 785 Medicare Part D claims totaling $113K in drug costs for 313 beneficiaries.
Where is NAYIRI ABNOUS located?
NAYIRI ABNOUS is located at 2619 E COLORADO BLVD STE 150, PASADENA, CA, 91107. Phone: (626) 793-4168.
What is NAYIRI ABNOUS's NPI number?
NAYIRI ABNOUS's National Provider Identifier (NPI) is 1295367399, issued on 02/06/2020.
Does NAYIRI ABNOUS prescribe more brand-name or generic drugs?
NAYIRI ABNOUS's prescribing is 45% brand-name and 55% generic drugs by claim count, with $104K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does NAYIRI ABNOUS prescribe most often?
Based on 2023 Medicare Part D data, NAYIRI ABNOUS's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAYIRI ABNOUS accept Medicare?
NAYIRI ABNOUS appears in CMS Medicare data with 785 Part D claims and 313 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAYIRI ABNOUS's credentials?
NAYIRI ABNOUS's NPI is 1295367399. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology